Active, not recruitingPhase 4NCT06678373

Monitoring JE Antibody Levels in Healthy Populations and Immunization Strategy in Low-Prevalence Areas

Studying Encephalitis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Liaoning Chengda Biotechnology CO., LTD
Principal Investigator
Xing Fang
Liaoning Provincial Center for Disease Control and Prevention
Intervention
Liaoning Chengda Inactivated Japanese Encephalitis Vaccine(biological)
Enrollment
250 enrolled
Eligibility
6 years · All sexes
Timeline
2024 – 2026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06678373 on ClinicalTrials.gov

Other trials for Encephalitis

Additional recruiting or active studies for the same condition.

See all trials for Encephalitis →

← Back to all trials